This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Emory University. Active years: 2024.
Company Filing History:
Years Active: 2024
Title: Anna Morris - Innovator in Cancer Treatment
Introduction
Anna Morris is a prominent inventor based in Atlanta, GA (US), known for her groundbreaking work in cancer treatment. With a focus on cell-based therapies, she has made significant contributions to the field of oncology. Her innovative approach aims to improve the management of cancer and chronic viral infections.
Latest Patents
Anna Morris holds a patent for "Methods of treating cancer using cell-based therapies." This patent discloses compositions and methods for reversing senescence in T cells by interrupting vasoactive intestinal peptide (VIP) signaling and/or inhibiting phosphatidylinositol-3-kinase (PI3 kinase) inhibitor signaling. The methods involve mixing T cells in vitro with agents that prevent VIP from interacting with VIP receptors and/or a PI3 kinase inhibitor. Additionally, the patent contemplates the expansion of senescent T cells through various combinations of agents.
Career Highlights
Anna is affiliated with Emory University, where she continues her research and development in cancer therapies. Her work has garnered attention for its potential to revolutionize treatment options for patients suffering from cancer and chronic viral infections.
Collaborations
Anna collaborates with esteemed colleagues, including Edmund K. Waller and Christopher Petersen, who contribute to her research endeavors and enhance the impact of her innovations.
Conclusion
Anna Morris is a trailblazer in the field of cancer treatment, with her innovative methods showing promise for improving patient outcomes. Her dedication to research and collaboration underscores her commitment to advancing medical science.